BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 418601)

  • 1. [Permanence and parellelism of serogroups of Pseudomonas aeruginosa in hospitalized patients (author's transl)].
    Ansorg R
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):191-6. PubMed ID: 418601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa strains from nosocomial pneumonia are more serum resistant than P. aeruginosa strains from noninfectious respiratory colonization processes.
    Vitkauskiene A; Scheuss S; Sakalauskas R; Dudzevicius V; Sahly H
    Infection; 2005 Oct; 33(5-6):356-61. PubMed ID: 16258867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on tissue affinity of serogroups of Pseudomonas aeruginosa (author's transl)].
    Ansorg R
    Med Microbiol Immunol; 1979; 167(4):269-73. PubMed ID: 120932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between serogroup, in vitro biofilm formation and elaboration of virulence factors by uropathogenic Pseudomonas aeruginosa.
    Mittal R; Sharma S; Chhibber S; Aggarwal S; Gupta V; Harjai K
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):237-43. PubMed ID: 19930457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
    Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
    Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotyping, sites of isolation and resistance of Pseudomonas aeruginosa.
    Dette GA; Knothe H; Schäfer V; Pirlet-Berninger U
    Microbiologica; 1988 Apr; 11(2):129-35. PubMed ID: 3136301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serotypes of Pseudomonas aeruginosa strains isolated from human sources in Diyarbakir (author's transl)].
    Yumul C
    Mikrobiyol Bul; 1980 Jan; 14(1):9-12. PubMed ID: 6779096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility profile of Pseudomonas aeruginosa isolates in Egypt.
    Gad GF; el-Domany RA; Ashour HM
    J Urol; 2008 Jul; 180(1):176-81. PubMed ID: 18499192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [O-antigen determination and identification of Pseudomonas aeruginosa (author's transl)].
    Ansorg R
    Zentralbl Bakteriol A; 1980 Mar; 246(2):197-203. PubMed ID: 6775439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trend of resistant Pseudomonas aeruginosa from field of clinical laboratory medicine].
    Oguri T; Misawa S; Igari J
    Nihon Rinsho; 1991 Oct; 49(10):2367-72. PubMed ID: 1749094
    [No Abstract]   [Full Text] [Related]  

  • 11. New Pseudomonas aeruginosa serotypes following the individualization of new antigenic "O" structures.
    Meitert E; Meitert T; Sima F; Savulian C; Butoianu A
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):161-78. PubMed ID: 120165
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence and persistence of polyagglutinable Pseudomonas aeruginosa in isolates from cystic fibrosis patients.
    Ojeniyi B; Høiby N; Rosdahl VT
    APMIS; 1991 Feb; 99(2):187-95. PubMed ID: 1900422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on serological classification of Pseudomonas aeruginosa using the indirect fluorescent antibody technique (author's transl)].
    Ansorg R; Weber R; Kleinmaier H
    Zentralbl Bakteriol Orig A; 1977; 237(2-3):280-96. PubMed ID: 403711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence of the "O" groups of "Pseudomonas aeruginosa" in the province of Valencia (Spain) (author's transl)].
    Sanchez-Buenaventura J; Patino J; Marti A; Mustieles ML
    Ann Microbiol (Paris); 1978; 129(2):161-5. PubMed ID: 98085
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of Pseudomonas aeruginosa serogroups in drinking water: use of serotyping in the control of water supplies.
    Kiss P; Lányi B; Bódi A; Fodré Z
    Acta Microbiol Hung; 1983; 30(2):131-7. PubMed ID: 6419534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriostatic activities in normal human serum against serologically classified Pseudomonas as aeruginosa from the urinary tract infection.
    Fujimura N; Yokoyama R
    Tokushima J Exp Med; 1978 Dec; 25(3-4):87-90. PubMed ID: 111374
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacterial infection agents in hospitalized patients].
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1986 Dec; 183(2-3):103-13. PubMed ID: 3107262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
    Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M
    Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.